Safety and Efficacy of Triple Antithrombotic Therapy with Dabigatran versus Vitamin K Antagonist in Atrial Fibrillation Patients: A Pilot Study

BACKGROUND: Combination of dual antiplatelet (DAPT) and oral anticoagulation therapy is required to decrease cardioembolic stroke and stent thrombosis risk in patients with atrial fibrillation (AF) and acute coronary syndrome (ACS). We compared the safety and efficacy of dabigatran etexilate with vi...

Descripción completa

Detalles Bibliográficos
Autores principales: Russo, Vincenzo, Rago, Anna, Proietti, Riccardo, Attena, Emilio, Rainone, Carmen, Crisci, Mario, Papa, Andrea Antonio, Calabrò, Paolo, D'Onofrio, Antonio, Golino, Paolo, Nigro, Gerardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393928/
https://www.ncbi.nlm.nih.gov/pubmed/30895193
http://dx.doi.org/10.1155/2019/5473240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393928/
https://www.ncbi.nlm.nih.gov/pubmed/30895193
http://dx.doi.org/10.1155/2019/5473240

Ejemplares similares